Filters

Digoxin Antibody, Biotin Conjugated

Digoxin Antibody, Biotin Conjugated size: 0.1ml 333

Price 333
Size 0.1ml
Long name Biotin Conjugated, Digoxin Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationBiotinylated
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenDigoxin
SpecificityThis is a highly specific antibody against Digoxin
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceBSA conjugated to Dig
Gene ID number4846
Tested applicationsIHC-P
Recommended dilutionsIHC-P(1:100-500)
CrossreactivityOthers
Crossreactive species detailsDigoxin
Antigen background Digitalis lanata, Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), It is also used to help normalize some dysrhythmias (abnormal types of heartbeat), and treat problems such as high blood pressure, Digoxin is a beta blocker drug originally derived from the foxglove plant
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation EmissionN/A
Synonyms Lanoxin, Digoxigenin
Properties Avidin and Streptavidin bind to the small biotin and are couple to HRP or AP for ELISA, Biotin conjugates can be detected by horseradish peroxidase, To break the streptavidin Biotin bond we suggest to use a 6 molar guanidine HCl solution with acidity of pH 1, alkaline phosphatase substrates or anti biotin conjugated antibodies, 6, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetDigoxin Conjugated
Short name Conjugated, Digoxin Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelBiotin
Alternative name biotinilated coupled, Digoxin (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter